RCAR
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2022 Q3 | 0.01 | $0 | -$148,218 |
| 2022 Q2 | -0.03 | $0 | -$2M |
| 2022 Q1 | -0.02 | $0 | -$2M |
| 2021 Q4 | -0.02 | $0 | -$572,573 |
| 2021 Q3 | -0.02 | $0 | -$921,213 |
| 2021 Q2 | -0.01 | $0 | -$1M |
| 2021 Q1 | -0.01 | $0 | -$2M |
| 2020 Q4 | -0.03 | $0 | -$1M |